Blaze Bioscience
company
About
Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $16.10M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. Tumor Paint provides real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors.
Blaze Bioscience was founded in 2010.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$16.10M
Blaze Bioscience has raised a total of
$16.10M
in funding over 2 rounds. Their latest funding was raised on
Oct 12, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 12, 2017 | Series B | $16.10M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Blaze Bioscience is funded by 3 investors.
B Cubed Ventures
and W&W Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
Keiretsu Forum
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
